3D | pharmaphorum

Digital

The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes.

News

Teva has made its first pipeline-building acquisition in almost a decade, buying Tourette syndrome drug developer Emalex for up to $900m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

3D